Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating whether vaccination with Gardasil-9 reduces infectivity and transmission of human papillomavirus in HPV-positive women;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Institut d'Investigació Biomèdica de Bellvitge | Conditions: HPV, High-risk HPV (Any Strain) | Phase 2 | Status: NOT_YET_RECRUITING